X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14653) 14653
Book Review (3338) 3338
Publication (632) 632
Book Chapter (62) 62
Magazine Article (44) 44
Book / eBook (35) 35
Conference Proceeding (35) 35
Reference (3) 3
Dissertation (2) 2
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13565) 13565
humans (12813) 12813
fibrinolytic agents - therapeutic use (7194) 7194
male (7160) 7160
fibrinolytic agents - administration & dosage (6967) 6967
female (6274) 6274
middle aged (4809) 4809
aged (4574) 4574
treatment outcome (3868) 3868
fibrinolytic agents - adverse effects (2788) 2788
peripheral vascular disease (2745) 2745
animals (2666) 2666
adult (2639) 2639
thrombolytic therapy (2517) 2517
time factors (2496) 2496
abridged index medicus (2348) 2348
tissue plasminogen activator - administration & dosage (2278) 2278
stroke (2235) 2235
thrombolysis (2182) 2182
tissue plasminogen activator - therapeutic use (2112) 2112
stroke - drug therapy (2012) 2012
risk factors (2000) 2000
aged, 80 and over (1895) 1895
fibrinolytic agents - pharmacology (1859) 1859
cardiac & cardiovascular systems (1847) 1847
thrombolytic therapy - methods (1679) 1679
clinical neurology (1654) 1654
myocardial infarction - drug therapy (1615) 1615
hematology (1497) 1497
retrospective studies (1477) 1477
therapy (1448) 1448
thrombosis (1339) 1339
surgery (1284) 1284
anticoagulants - therapeutic use (1229) 1229
tissue plasminogen activator (1194) 1194
care and treatment (1115) 1115
brain ischemia - drug therapy (1038) 1038
anticoagulants - administration & dosage (1026) 1026
prospective studies (1020) 1020
mortality (1016) 1016
drug therapy, combination (1013) 1013
acute ischemic-stroke (1009) 1009
tissue-plasminogen activator (1008) 1008
pharmacology & pharmacy (1005) 1005
thrombosis - drug therapy (975) 975
rats (970) 970
anticoagulants (965) 965
medicine, general & internal (954) 954
acute disease (952) 952
management (923) 923
platelet aggregation inhibitors - therapeutic use (894) 894
drug therapy (893) 893
infusions, intravenous (893) 893
heparin - therapeutic use (887) 887
neurosciences (887) 887
dose-response relationship, drug (879) 879
heparin - administration & dosage (875) 875
follow-up studies (866) 866
ischemia (854) 854
trial (853) 853
thrombolytic therapy - adverse effects (842) 842
aspirin (817) 817
heparin (813) 813
acute myocardial-infarction (809) 809
tissue plasminogen activator - adverse effects (794) 794
medicine & public health (776) 776
alteplase (774) 774
hemorrhage - chemically induced (770) 770
prevention (766) 766
neurology (750) 750
fibrinolysis (716) 716
analysis (714) 714
administration, oral (713) 713
risk assessment (691) 691
risk (684) 684
injections, intravenous (683) 683
disease models, animal (676) 676
myocardial infarction - therapy (676) 676
randomized controlled trials as topic (666) 666
thrombosis - prevention & control (665) 665
aspirin - therapeutic use (656) 656
aspirin - administration & dosage (651) 651
clinical trials as topic (642) 642
recombinant proteins - therapeutic use (639) 639
platelet aggregation inhibitors - administration & dosage (632) 632
cardiology (629) 629
heart attacks (625) 625
drug administration schedule (623) 623
health aspects (623) 623
molecular-weight heparin (619) 619
cardiovascular (616) 616
prognosis (590) 590
electrocardiography (585) 585
streptokinase - administration & dosage (577) 577
thromboembolism (576) 576
stroke - etiology (570) 570
anticoagulants - adverse effects (568) 568
tomography, x-ray computed (566) 566
recurrence (564) 564
streptokinase - therapeutic use (562) 562
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (29) 29
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13104) 13104
German (417) 417
French (246) 246
Russian (232) 232
Spanish (154) 154
Japanese (119) 119
Italian (112) 112
Norwegian (59) 59
Danish (55) 55
Polish (55) 55
Chinese (49) 49
Swedish (39) 39
Hungarian (32) 32
Czech (17) 17
Turkish (15) 15
Dutch (14) 14
Finnish (11) 11
Portuguese (9) 9
Lithuanian (8) 8
Hebrew (7) 7
Romanian (7) 7
Ukrainian (7) 7
Bulgarian (5) 5
Serbian (5) 5
Croatian (3) 3
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 8, pp. 699 - 708
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9834, pp. 2352 - 2363
Journal Article